nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Tamoxifen—pancreatic cancer	0.132	0.28	CbGbCtD
Memantine—CYP2A6—Fluorouracil—pancreatic cancer	0.0975	0.206	CbGbCtD
Memantine—CYP2B6—Tamoxifen—pancreatic cancer	0.0861	0.182	CbGbCtD
Memantine—CYP2B6—Irinotecan—pancreatic cancer	0.0661	0.14	CbGbCtD
Memantine—CYP2C19—Tamoxifen—pancreatic cancer	0.0547	0.116	CbGbCtD
Memantine—CYP2B6—Doxorubicin—pancreatic cancer	0.0361	0.0764	CbGbCtD
Memantine—HTR3A—enteric nervous system—pancreatic cancer	0.0201	0.779	CbGeAlD
Memantine—HTR3A—islet of Langerhans—pancreatic cancer	0.00192	0.0744	CbGeAlD
Memantine—SLC22A2—digestive system—pancreatic cancer	0.00134	0.0518	CbGeAlD
Memantine—HTR3A—digestive system—pancreatic cancer	0.00116	0.0447	CbGeAlD
Memantine—CYP2C19—digestive system—pancreatic cancer	0.00073	0.0282	CbGeAlD
Memantine—CYP2B6—digestive system—pancreatic cancer	0.000572	0.0221	CbGeAlD
Memantine—Haematuria—Epirubicin—pancreatic cancer	0.000144	0.000324	CcSEcCtD
Memantine—Confusional state—Docetaxel—pancreatic cancer	0.000144	0.000324	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000143	0.000321	CcSEcCtD
Memantine—Oedema—Docetaxel—pancreatic cancer	0.000143	0.000321	CcSEcCtD
Memantine—Weight increased—Doxorubicin—pancreatic cancer	0.000142	0.000321	CcSEcCtD
Memantine—Epistaxis—Epirubicin—pancreatic cancer	0.000142	0.00032	CcSEcCtD
Memantine—Pruritus—Gemcitabine—pancreatic cancer	0.000142	0.00032	CcSEcCtD
Memantine—Infection—Docetaxel—pancreatic cancer	0.000142	0.000319	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—pancreatic cancer	0.000142	0.000319	CcSEcCtD
Memantine—Sinusitis—Epirubicin—pancreatic cancer	0.000142	0.000319	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000141	0.000318	CcSEcCtD
Memantine—Diarrhoea—Irinotecan—pancreatic cancer	0.000141	0.000318	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000141	0.000317	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—pancreatic cancer	0.00014	0.000316	CcSEcCtD
Memantine—Shock—Docetaxel—pancreatic cancer	0.00014	0.000316	CcSEcCtD
Memantine—Nervous system disorder—Docetaxel—pancreatic cancer	0.00014	0.000315	CcSEcCtD
Memantine—Pruritus—Fluorouracil—pancreatic cancer	0.00014	0.000315	CcSEcCtD
Memantine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00014	0.000314	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—pancreatic cancer	0.00014	0.000314	CcSEcCtD
Memantine—Infestation—Doxorubicin—pancreatic cancer	0.00014	0.000314	CcSEcCtD
Memantine—Tachycardia—Docetaxel—pancreatic cancer	0.000139	0.000313	CcSEcCtD
Memantine—Skin disorder—Docetaxel—pancreatic cancer	0.000139	0.000312	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000138	0.000312	CcSEcCtD
Memantine—Bradycardia—Epirubicin—pancreatic cancer	0.000138	0.00031	CcSEcCtD
Memantine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000138	0.00031	CcSEcCtD
Memantine—Renal failure—Doxorubicin—pancreatic cancer	0.000137	0.000309	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000137	0.000308	CcSEcCtD
Memantine—Dizziness—Irinotecan—pancreatic cancer	0.000136	0.000307	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—pancreatic cancer	0.000136	0.000306	CcSEcCtD
Memantine—Anorexia—Docetaxel—pancreatic cancer	0.000136	0.000306	CcSEcCtD
Memantine—Rhinitis—Epirubicin—pancreatic cancer	0.000136	0.000306	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000136	0.000306	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000136	0.000306	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—pancreatic cancer	0.000135	0.000305	CcSEcCtD
Memantine—Hepatitis—Epirubicin—pancreatic cancer	0.000135	0.000305	CcSEcCtD
Memantine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000135	0.000304	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000135	0.000303	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—pancreatic cancer	0.000134	0.000303	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000134	0.000301	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000133	0.0003	CcSEcCtD
Memantine—Hypotension—Docetaxel—pancreatic cancer	0.000133	0.0003	CcSEcCtD
Memantine—Haematuria—Doxorubicin—pancreatic cancer	0.000133	0.0003	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000133	0.0003	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—pancreatic cancer	0.000133	0.000299	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000132	0.000297	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—pancreatic cancer	0.000132	0.000296	CcSEcCtD
Memantine—Vomiting—Irinotecan—pancreatic cancer	0.000131	0.000295	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—pancreatic cancer	0.000131	0.000295	CcSEcCtD
Memantine—Dizziness—Fluorouracil—pancreatic cancer	0.000131	0.000294	CcSEcCtD
Memantine—Visual impairment—Epirubicin—pancreatic cancer	0.000131	0.000294	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00013	0.000293	CcSEcCtD
Memantine—Rash—Irinotecan—pancreatic cancer	0.00013	0.000293	CcSEcCtD
Memantine—Dermatitis—Irinotecan—pancreatic cancer	0.00013	0.000293	CcSEcCtD
Memantine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00013	0.000293	CcSEcCtD
Memantine—Headache—Irinotecan—pancreatic cancer	0.000129	0.000291	CcSEcCtD
Memantine—Insomnia—Docetaxel—pancreatic cancer	0.000129	0.000291	CcSEcCtD
Memantine—Paraesthesia—Docetaxel—pancreatic cancer	0.000128	0.000288	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000128	0.000288	CcSEcCtD
Memantine—Vomiting—Gemcitabine—pancreatic cancer	0.000128	0.000288	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—pancreatic cancer	0.000128	0.000287	CcSEcCtD
Memantine—Dyspnoea—Docetaxel—pancreatic cancer	0.000127	0.000286	CcSEcCtD
Memantine—Somnolence—Docetaxel—pancreatic cancer	0.000127	0.000286	CcSEcCtD
Memantine—Rash—Gemcitabine—pancreatic cancer	0.000127	0.000285	CcSEcCtD
Memantine—Dermatitis—Gemcitabine—pancreatic cancer	0.000127	0.000285	CcSEcCtD
Memantine—Eye disorder—Epirubicin—pancreatic cancer	0.000127	0.000285	CcSEcCtD
Memantine—Tinnitus—Epirubicin—pancreatic cancer	0.000126	0.000284	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000126	0.000284	CcSEcCtD
Memantine—Headache—Gemcitabine—pancreatic cancer	0.000126	0.000284	CcSEcCtD
Memantine—Flushing—Epirubicin—pancreatic cancer	0.000126	0.000283	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000126	0.000283	CcSEcCtD
Memantine—Vomiting—Fluorouracil—pancreatic cancer	0.000126	0.000283	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—pancreatic cancer	0.000126	0.000283	CcSEcCtD
Memantine—Dyspepsia—Docetaxel—pancreatic cancer	0.000126	0.000283	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—pancreatic cancer	0.000125	0.000282	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000125	0.000282	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000125	0.000281	CcSEcCtD
Memantine—Rash—Fluorouracil—pancreatic cancer	0.000125	0.000281	CcSEcCtD
Memantine—Dermatitis—Fluorouracil—pancreatic cancer	0.000125	0.00028	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000124	0.00028	CcSEcCtD
Memantine—Decreased appetite—Docetaxel—pancreatic cancer	0.000124	0.000279	CcSEcCtD
Memantine—Headache—Fluorouracil—pancreatic cancer	0.000124	0.000279	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000124	0.000279	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000123	0.000278	CcSEcCtD
Memantine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000123	0.000277	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000123	0.000277	CcSEcCtD
Memantine—Fatigue—Docetaxel—pancreatic cancer	0.000123	0.000277	CcSEcCtD
Memantine—Angiopathy—Epirubicin—pancreatic cancer	0.000123	0.000277	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000123	0.000277	CcSEcCtD
Memantine—Nausea—Irinotecan—pancreatic cancer	0.000123	0.000276	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—pancreatic cancer	0.000122	0.000275	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000122	0.000275	CcSEcCtD
Memantine—Constipation—Docetaxel—pancreatic cancer	0.000122	0.000275	CcSEcCtD
Memantine—Pain—Docetaxel—pancreatic cancer	0.000122	0.000275	CcSEcCtD
Memantine—Chills—Epirubicin—pancreatic cancer	0.000122	0.000274	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—pancreatic cancer	0.000121	0.000272	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—pancreatic cancer	0.000121	0.000272	CcSEcCtD
Memantine—Alopecia—Epirubicin—pancreatic cancer	0.00012	0.000269	CcSEcCtD
Memantine—Nausea—Gemcitabine—pancreatic cancer	0.000119	0.000269	CcSEcCtD
Memantine—Mental disorder—Epirubicin—pancreatic cancer	0.000119	0.000267	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000118	0.000267	CcSEcCtD
Memantine—Malnutrition—Epirubicin—pancreatic cancer	0.000118	0.000265	CcSEcCtD
Memantine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000118	0.000265	CcSEcCtD
Memantine—Nausea—Fluorouracil—pancreatic cancer	0.000117	0.000264	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—pancreatic cancer	0.000117	0.000264	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—pancreatic cancer	0.000117	0.000263	CcSEcCtD
Memantine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000117	0.000263	CcSEcCtD
Memantine—Flushing—Doxorubicin—pancreatic cancer	0.000116	0.000262	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000116	0.000262	CcSEcCtD
Memantine—Flatulence—Epirubicin—pancreatic cancer	0.000116	0.000262	CcSEcCtD
Memantine—Tension—Epirubicin—pancreatic cancer	0.000116	0.00026	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—pancreatic cancer	0.000115	0.00026	CcSEcCtD
Memantine—Nervousness—Epirubicin—pancreatic cancer	0.000115	0.000258	CcSEcCtD
Memantine—Back pain—Epirubicin—pancreatic cancer	0.000114	0.000257	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—pancreatic cancer	0.000114	0.000256	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000113	0.000255	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000113	0.000254	CcSEcCtD
Memantine—Abdominal pain—Docetaxel—pancreatic cancer	0.000113	0.000254	CcSEcCtD
Memantine—Body temperature increased—Docetaxel—pancreatic cancer	0.000113	0.000254	CcSEcCtD
Memantine—Chills—Doxorubicin—pancreatic cancer	0.000112	0.000253	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000112	0.000252	CcSEcCtD
Memantine—Vision blurred—Epirubicin—pancreatic cancer	0.000111	0.00025	CcSEcCtD
Memantine—Alopecia—Doxorubicin—pancreatic cancer	0.000111	0.000249	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—pancreatic cancer	0.00011	0.000247	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000109	0.000246	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—pancreatic cancer	0.000109	0.000246	CcSEcCtD
Memantine—Anaemia—Epirubicin—pancreatic cancer	0.000109	0.000245	CcSEcCtD
Memantine—Agitation—Epirubicin—pancreatic cancer	0.000108	0.000244	CcSEcCtD
Memantine—Flatulence—Doxorubicin—pancreatic cancer	0.000107	0.000242	CcSEcCtD
Memantine—Tension—Doxorubicin—pancreatic cancer	0.000107	0.000241	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000107	0.000241	CcSEcCtD
Memantine—Malaise—Epirubicin—pancreatic cancer	0.000106	0.000239	CcSEcCtD
Memantine—Nervousness—Doxorubicin—pancreatic cancer	0.000106	0.000239	CcSEcCtD
Memantine—Vertigo—Epirubicin—pancreatic cancer	0.000106	0.000239	CcSEcCtD
Memantine—Syncope—Epirubicin—pancreatic cancer	0.000106	0.000238	CcSEcCtD
Memantine—Leukopenia—Epirubicin—pancreatic cancer	0.000106	0.000238	CcSEcCtD
Memantine—Back pain—Doxorubicin—pancreatic cancer	0.000106	0.000238	CcSEcCtD
Memantine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000105	0.000237	CcSEcCtD
Memantine—Palpitations—Epirubicin—pancreatic cancer	0.000104	0.000235	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000104	0.000233	CcSEcCtD
Memantine—Cough—Epirubicin—pancreatic cancer	0.000103	0.000232	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—pancreatic cancer	0.000103	0.000231	CcSEcCtD
Memantine—Asthenia—Docetaxel—pancreatic cancer	0.000102	0.00023	CcSEcCtD
Memantine—Convulsion—Epirubicin—pancreatic cancer	0.000102	0.00023	CcSEcCtD
Memantine—Hypertension—Epirubicin—pancreatic cancer	0.000102	0.000229	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000101	0.000228	CcSEcCtD
Memantine—Pruritus—Docetaxel—pancreatic cancer	0.000101	0.000227	CcSEcCtD
Memantine—Anaemia—Doxorubicin—pancreatic cancer	0.000101	0.000227	CcSEcCtD
Memantine—Chest pain—Epirubicin—pancreatic cancer	0.0001	0.000226	CcSEcCtD
Memantine—Myalgia—Epirubicin—pancreatic cancer	0.0001	0.000226	CcSEcCtD
Memantine—Arthralgia—Epirubicin—pancreatic cancer	0.0001	0.000226	CcSEcCtD
Memantine—Agitation—Doxorubicin—pancreatic cancer	0.0001	0.000226	CcSEcCtD
Memantine—Anxiety—Epirubicin—pancreatic cancer	0.0001	0.000225	CcSEcCtD
Memantine—Discomfort—Epirubicin—pancreatic cancer	9.92e-05	0.000223	CcSEcCtD
Memantine—Malaise—Doxorubicin—pancreatic cancer	9.84e-05	0.000222	CcSEcCtD
Memantine—Dry mouth—Epirubicin—pancreatic cancer	9.82e-05	0.000221	CcSEcCtD
Memantine—Vertigo—Doxorubicin—pancreatic cancer	9.8e-05	0.000221	CcSEcCtD
Memantine—Syncope—Doxorubicin—pancreatic cancer	9.78e-05	0.00022	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—pancreatic cancer	9.76e-05	0.00022	CcSEcCtD
Memantine—Diarrhoea—Docetaxel—pancreatic cancer	9.76e-05	0.00022	CcSEcCtD
Memantine—Confusional state—Epirubicin—pancreatic cancer	9.7e-05	0.000218	CcSEcCtD
Memantine—Palpitations—Doxorubicin—pancreatic cancer	9.64e-05	0.000217	CcSEcCtD
Memantine—Oedema—Epirubicin—pancreatic cancer	9.62e-05	0.000217	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—pancreatic cancer	9.59e-05	0.000216	CcSEcCtD
Memantine—Infection—Epirubicin—pancreatic cancer	9.56e-05	0.000215	CcSEcCtD
Memantine—Cough—Doxorubicin—pancreatic cancer	9.52e-05	0.000214	CcSEcCtD
Memantine—Shock—Epirubicin—pancreatic cancer	9.47e-05	0.000213	CcSEcCtD
Memantine—Convulsion—Doxorubicin—pancreatic cancer	9.45e-05	0.000213	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—pancreatic cancer	9.44e-05	0.000212	CcSEcCtD
Memantine—Dizziness—Docetaxel—pancreatic cancer	9.43e-05	0.000212	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—pancreatic cancer	9.42e-05	0.000212	CcSEcCtD
Memantine—Hypertension—Doxorubicin—pancreatic cancer	9.42e-05	0.000212	CcSEcCtD
Memantine—Tachycardia—Epirubicin—pancreatic cancer	9.39e-05	0.000211	CcSEcCtD
Memantine—Skin disorder—Epirubicin—pancreatic cancer	9.35e-05	0.00021	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—pancreatic cancer	9.3e-05	0.000209	CcSEcCtD
Memantine—Myalgia—Doxorubicin—pancreatic cancer	9.29e-05	0.000209	CcSEcCtD
Memantine—Chest pain—Doxorubicin—pancreatic cancer	9.29e-05	0.000209	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—pancreatic cancer	9.29e-05	0.000209	CcSEcCtD
Memantine—Anxiety—Doxorubicin—pancreatic cancer	9.26e-05	0.000208	CcSEcCtD
Memantine—Discomfort—Doxorubicin—pancreatic cancer	9.18e-05	0.000207	CcSEcCtD
Memantine—Anorexia—Epirubicin—pancreatic cancer	9.17e-05	0.000207	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—pancreatic cancer	9.08e-05	0.000205	CcSEcCtD
Memantine—Vomiting—Docetaxel—pancreatic cancer	9.07e-05	0.000204	CcSEcCtD
Memantine—Rash—Docetaxel—pancreatic cancer	8.99e-05	0.000203	CcSEcCtD
Memantine—Hypotension—Epirubicin—pancreatic cancer	8.99e-05	0.000202	CcSEcCtD
Memantine—Dermatitis—Docetaxel—pancreatic cancer	8.99e-05	0.000202	CcSEcCtD
Memantine—Confusional state—Doxorubicin—pancreatic cancer	8.98e-05	0.000202	CcSEcCtD
Memantine—Headache—Docetaxel—pancreatic cancer	8.94e-05	0.000201	CcSEcCtD
Memantine—Oedema—Doxorubicin—pancreatic cancer	8.9e-05	0.0002	CcSEcCtD
Memantine—Infection—Doxorubicin—pancreatic cancer	8.85e-05	0.000199	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.77e-05	0.000197	CcSEcCtD
Memantine—Shock—Doxorubicin—pancreatic cancer	8.76e-05	0.000197	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—pancreatic cancer	8.73e-05	0.000197	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.72e-05	0.000196	CcSEcCtD
Memantine—Insomnia—Epirubicin—pancreatic cancer	8.7e-05	0.000196	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—pancreatic cancer	8.69e-05	0.000196	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—pancreatic cancer	8.65e-05	0.000195	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—pancreatic cancer	8.64e-05	0.000195	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.61e-05	0.000194	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—pancreatic cancer	8.58e-05	0.000193	CcSEcCtD
Memantine—Somnolence—Epirubicin—pancreatic cancer	8.55e-05	0.000193	CcSEcCtD
Memantine—Anorexia—Doxorubicin—pancreatic cancer	8.49e-05	0.000191	CcSEcCtD
Memantine—Nausea—Docetaxel—pancreatic cancer	8.47e-05	0.000191	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—pancreatic cancer	8.47e-05	0.000191	CcSEcCtD
Memantine—Decreased appetite—Epirubicin—pancreatic cancer	8.36e-05	0.000188	CcSEcCtD
Memantine—Hypotension—Doxorubicin—pancreatic cancer	8.32e-05	0.000187	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	8.31e-05	0.000187	CcSEcCtD
Memantine—Fatigue—Epirubicin—pancreatic cancer	8.3e-05	0.000187	CcSEcCtD
Memantine—Constipation—Epirubicin—pancreatic cancer	8.23e-05	0.000185	CcSEcCtD
Memantine—Pain—Epirubicin—pancreatic cancer	8.23e-05	0.000185	CcSEcCtD
Memantine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.11e-05	0.000183	CcSEcCtD
Memantine—Insomnia—Doxorubicin—pancreatic cancer	8.05e-05	0.000181	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—pancreatic cancer	7.99e-05	0.00018	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—pancreatic cancer	7.94e-05	0.000179	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—pancreatic cancer	7.93e-05	0.000179	CcSEcCtD
Memantine—Somnolence—Doxorubicin—pancreatic cancer	7.92e-05	0.000178	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.87e-05	0.000177	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—pancreatic cancer	7.84e-05	0.000176	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—pancreatic cancer	7.74e-05	0.000174	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.69e-05	0.000173	CcSEcCtD
Memantine—Fatigue—Doxorubicin—pancreatic cancer	7.68e-05	0.000173	CcSEcCtD
Memantine—Urticaria—Epirubicin—pancreatic cancer	7.64e-05	0.000172	CcSEcCtD
Memantine—Pain—Doxorubicin—pancreatic cancer	7.61e-05	0.000171	CcSEcCtD
Memantine—Constipation—Doxorubicin—pancreatic cancer	7.61e-05	0.000171	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—pancreatic cancer	7.61e-05	0.000171	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—pancreatic cancer	7.61e-05	0.000171	CcSEcCtD
Memantine—Feeling abnormal—Doxorubicin—pancreatic cancer	7.34e-05	0.000165	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.28e-05	0.000164	CcSEcCtD
Memantine—Hypersensitivity—Epirubicin—pancreatic cancer	7.09e-05	0.00016	CcSEcCtD
Memantine—Urticaria—Doxorubicin—pancreatic cancer	7.07e-05	0.000159	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—pancreatic cancer	7.04e-05	0.000158	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—pancreatic cancer	7.04e-05	0.000158	CcSEcCtD
Memantine—Asthenia—Epirubicin—pancreatic cancer	6.9e-05	0.000155	CcSEcCtD
Memantine—Pruritus—Epirubicin—pancreatic cancer	6.81e-05	0.000153	CcSEcCtD
Memantine—Diarrhoea—Epirubicin—pancreatic cancer	6.58e-05	0.000148	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—pancreatic cancer	6.56e-05	0.000148	CcSEcCtD
Memantine—Asthenia—Doxorubicin—pancreatic cancer	6.39e-05	0.000144	CcSEcCtD
Memantine—Dizziness—Epirubicin—pancreatic cancer	6.36e-05	0.000143	CcSEcCtD
Memantine—Pruritus—Doxorubicin—pancreatic cancer	6.3e-05	0.000142	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—SSTR1—pancreatic cancer	6.18e-05	0.00108	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.18e-05	0.00108	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP2—pancreatic cancer	6.15e-05	0.00107	CbGpPWpGaD
Memantine—Vomiting—Epirubicin—pancreatic cancer	6.12e-05	0.000138	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—CNR1—pancreatic cancer	6.09e-05	0.00106	CbGpPWpGaD
Memantine—Diarrhoea—Doxorubicin—pancreatic cancer	6.09e-05	0.000137	CcSEcCtD
Memantine—Rash—Epirubicin—pancreatic cancer	6.07e-05	0.000137	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—PPY—pancreatic cancer	6.06e-05	0.00106	CbGpPWpGaD
Memantine—Dermatitis—Epirubicin—pancreatic cancer	6.06e-05	0.000136	CcSEcCtD
Memantine—Headache—Epirubicin—pancreatic cancer	6.03e-05	0.000136	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.03e-05	0.00105	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP2—pancreatic cancer	6e-05	0.00105	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—SRC—pancreatic cancer	5.97e-05	0.00104	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SSTR2—pancreatic cancer	5.95e-05	0.00104	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—pancreatic cancer	5.89e-05	0.000133	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—GCG—pancreatic cancer	5.88e-05	0.00103	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—SRC—pancreatic cancer	5.82e-05	0.00102	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—pancreatic cancer	5.82e-05	0.00101	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCKBR—pancreatic cancer	5.75e-05	0.001	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—pancreatic cancer	5.75e-05	0.001	CbGpPWpGaD
Memantine—Nausea—Epirubicin—pancreatic cancer	5.72e-05	0.000129	CcSEcCtD
Memantine—SLC22A2—Metabolism—PRSS1—pancreatic cancer	5.71e-05	0.000996	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—pancreatic cancer	5.67e-05	0.000989	CbGpPWpGaD
Memantine—Vomiting—Doxorubicin—pancreatic cancer	5.66e-05	0.000127	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—AGTR1—pancreatic cancer	5.61e-05	0.000979	CbGpPWpGaD
Memantine—Rash—Doxorubicin—pancreatic cancer	5.61e-05	0.000126	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—pancreatic cancer	5.61e-05	0.000126	CcSEcCtD
Memantine—GRIN2B—Axon guidance—NRAS—pancreatic cancer	5.6e-05	0.000977	CbGpPWpGaD
Memantine—Headache—Doxorubicin—pancreatic cancer	5.58e-05	0.000126	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—GAST—pancreatic cancer	5.44e-05	0.000949	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—pancreatic cancer	5.43e-05	0.000947	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—pancreatic cancer	5.29e-05	0.000119	CcSEcCtD
Memantine—CYP2A6—Metabolism—PRSS1—pancreatic cancer	5.24e-05	0.000914	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—pancreatic cancer	5.23e-05	0.000913	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SCT—pancreatic cancer	5.16e-05	0.0009	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—pancreatic cancer	5.1e-05	0.00089	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ARG2—pancreatic cancer	4.95e-05	0.000863	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—pancreatic cancer	4.94e-05	0.000862	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GAST—pancreatic cancer	4.94e-05	0.000862	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCK—pancreatic cancer	4.92e-05	0.000859	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	4.82e-05	0.000841	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—pancreatic cancer	4.82e-05	0.000841	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CNR2—pancreatic cancer	4.8e-05	0.000837	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GLP1R—pancreatic cancer	4.8e-05	0.000837	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—pancreatic cancer	4.74e-05	0.000826	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCKAR—pancreatic cancer	4.72e-05	0.000823	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—pancreatic cancer	4.71e-05	0.000822	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SCT—pancreatic cancer	4.69e-05	0.000817	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—pancreatic cancer	4.62e-05	0.000806	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—pancreatic cancer	4.62e-05	0.000805	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—pancreatic cancer	4.6e-05	0.000802	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ARG2—pancreatic cancer	4.54e-05	0.000792	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—pancreatic cancer	4.51e-05	0.000786	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRLHR—pancreatic cancer	4.48e-05	0.000781	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCK—pancreatic cancer	4.47e-05	0.00078	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CNR2—pancreatic cancer	4.36e-05	0.00076	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GLP1R—pancreatic cancer	4.36e-05	0.00076	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—pancreatic cancer	4.33e-05	0.000755	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMP—pancreatic cancer	4.33e-05	0.000755	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCKAR—pancreatic cancer	4.29e-05	0.000747	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—SRC—pancreatic cancer	4.26e-05	0.000743	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IAPP—pancreatic cancer	4.25e-05	0.000741	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—pancreatic cancer	4.25e-05	0.000741	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PRSS1—pancreatic cancer	4.23e-05	0.000737	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ZNRF3—pancreatic cancer	4.21e-05	0.000735	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ACVR1B—pancreatic cancer	4.21e-05	0.000735	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—pancreatic cancer	4.2e-05	0.000733	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—SRC—pancreatic cancer	4.15e-05	0.000724	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—pancreatic cancer	4.15e-05	0.000724	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—pancreatic cancer	4.11e-05	0.000717	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—pancreatic cancer	4.1e-05	0.000715	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—pancreatic cancer	4.1e-05	0.000715	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTHLH—pancreatic cancer	4.08e-05	0.000711	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—pancreatic cancer	4.05e-05	0.000706	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—pancreatic cancer	4.01e-05	0.000699	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—pancreatic cancer	4e-05	0.000697	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMP—pancreatic cancer	3.97e-05	0.000693	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SHH—pancreatic cancer	3.91e-05	0.000681	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IAPP—pancreatic cancer	3.86e-05	0.000673	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR3—pancreatic cancer	3.81e-05	0.000664	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DTX1—pancreatic cancer	3.81e-05	0.000664	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—pancreatic cancer	3.81e-05	0.000664	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—pancreatic cancer	3.74e-05	0.000651	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SST—pancreatic cancer	3.73e-05	0.000651	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—pancreatic cancer	3.71e-05	0.000648	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTHLH—pancreatic cancer	3.7e-05	0.000646	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTCH1—pancreatic cancer	3.7e-05	0.000646	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ARG2—pancreatic cancer	3.67e-05	0.000639	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR1—pancreatic cancer	3.65e-05	0.000637	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—pancreatic cancer	3.64e-05	0.000635	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPY—pancreatic cancer	3.58e-05	0.000625	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—pancreatic cancer	3.56e-05	0.00062	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—pancreatic cancer	3.53e-05	0.000615	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR2—pancreatic cancer	3.52e-05	0.000613	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GLP1R—pancreatic cancer	3.49e-05	0.000608	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—pancreatic cancer	3.47e-05	0.000605	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CNR1—pancreatic cancer	3.44e-05	0.0006	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—pancreatic cancer	3.44e-05	0.0006	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—DPYD—pancreatic cancer	3.43e-05	0.000598	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCKBR—pancreatic cancer	3.4e-05	0.000592	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SST—pancreatic cancer	3.39e-05	0.000591	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.38e-05	0.000589	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GCG—pancreatic cancer	3.33e-05	0.00058	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	3.26e-05	0.000568	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.21e-05	0.000561	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMP—pancreatic cancer	3.2e-05	0.000559	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GLP1R—pancreatic cancer	3.2e-05	0.000558	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	3.2e-05	0.000557	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GLI1—pancreatic cancer	3.19e-05	0.000557	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DTX4—pancreatic cancer	3.19e-05	0.000557	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGTR1—pancreatic cancer	3.17e-05	0.000553	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—DPYD—pancreatic cancer	3.15e-05	0.000549	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CNR1—pancreatic cancer	3.13e-05	0.000545	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRP1—pancreatic cancer	3.11e-05	0.000542	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP2R5B—pancreatic cancer	3.11e-05	0.000542	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GCG—pancreatic cancer	3.02e-05	0.000527	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—pancreatic cancer	3e-05	0.000523	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEY2—pancreatic cancer	2.99e-05	0.000521	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	2.99e-05	0.000521	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—pancreatic cancer	2.95e-05	0.000515	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—pancreatic cancer	2.92e-05	0.00051	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GAST—pancreatic cancer	2.92e-05	0.000509	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGTR1—pancreatic cancer	2.88e-05	0.000502	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.77e-05	0.000483	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SCT—pancreatic cancer	2.77e-05	0.000483	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEY1—pancreatic cancer	2.77e-05	0.000483	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—pancreatic cancer	2.65e-05	0.000462	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCK—pancreatic cancer	2.64e-05	0.000461	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.58e-05	0.00045	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—pancreatic cancer	2.58e-05	0.00045	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GLP1R—pancreatic cancer	2.57e-05	0.000449	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR2—pancreatic cancer	2.57e-05	0.000449	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—pancreatic cancer	2.57e-05	0.000449	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.54e-05	0.000443	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCKAR—pancreatic cancer	2.53e-05	0.000442	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CD44—pancreatic cancer	2.52e-05	0.00044	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	2.46e-05	0.000429	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAG2—pancreatic cancer	2.46e-05	0.000428	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.42e-05	0.000422	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MEN1—pancreatic cancer	2.42e-05	0.000422	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GCG—pancreatic cancer	2.42e-05	0.000422	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	2.41e-05	0.000421	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CD44—pancreatic cancer	2.31e-05	0.000404	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SHH—pancreatic cancer	2.31e-05	0.000403	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH4—pancreatic cancer	2.29e-05	0.0004	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IAPP—pancreatic cancer	2.28e-05	0.000398	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—STK11—pancreatic cancer	2.27e-05	0.000396	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GCG—pancreatic cancer	2.22e-05	0.000387	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTHLH—pancreatic cancer	2.19e-05	0.000382	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTCH1—pancreatic cancer	2.19e-05	0.000382	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—STK11—pancreatic cancer	2.09e-05	0.000364	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SST—pancreatic cancer	2e-05	0.000349	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2e-05	0.000348	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.97e-05	0.000344	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAG1—pancreatic cancer	1.96e-05	0.000342	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—pancreatic cancer	1.96e-05	0.000341	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.95e-05	0.00034	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	1.95e-05	0.00034	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.000335	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CD44—pancreatic cancer	1.87e-05	0.000326	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR1—pancreatic cancer	1.85e-05	0.000322	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.82e-05	0.000318	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.8e-05	0.000315	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—pancreatic cancer	1.79e-05	0.000313	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	1.79e-05	0.000313	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCG—pancreatic cancer	1.79e-05	0.000312	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GCG—pancreatic cancer	1.78e-05	0.000311	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.74e-05	0.000304	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.74e-05	0.000303	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.7e-05	0.000297	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—STK11—pancreatic cancer	1.68e-05	0.000294	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.68e-05	0.000293	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—pancreatic cancer	1.59e-05	0.000277	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.59e-05	0.000276	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.58e-05	0.000275	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.51e-05	0.000264	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.47e-05	0.000256	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—pancreatic cancer	1.46e-05	0.000255	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.45e-05	0.000253	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.45e-05	0.000253	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	1.44e-05	0.00025	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.43e-05	0.00025	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000246	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—pancreatic cancer	1.39e-05	0.000242	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.38e-05	0.000241	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.37e-05	0.00024	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.37e-05	0.000239	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCG—pancreatic cancer	1.35e-05	0.000236	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.32e-05	0.00023	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	1.32e-05	0.00023	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000222	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—pancreatic cancer	1.27e-05	0.000222	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	1.26e-05	0.00022	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.26e-05	0.000219	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.2e-05	0.00021	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.2e-05	0.000209	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.19e-05	0.000208	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—pancreatic cancer	1.18e-05	0.000205	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.17e-05	0.000205	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	1.16e-05	0.000202	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.15e-05	0.0002	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.1e-05	0.000192	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.09e-05	0.000191	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.09e-05	0.000191	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.09e-05	0.00019	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.08e-05	0.000189	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	0.000185	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.06e-05	0.000185	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.06e-05	0.000185	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.05e-05	0.000183	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—pancreatic cancer	1.03e-05	0.000179	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.000176	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—pancreatic cancer	1e-05	0.000174	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	9.65e-06	0.000168	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—pancreatic cancer	9.5e-06	0.000166	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	9.34e-06	0.000163	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	9.31e-06	0.000162	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.22e-06	0.000161	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	9.11e-06	0.000159	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—pancreatic cancer	8.9e-06	0.000155	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—pancreatic cancer	8.72e-06	0.000152	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.42e-06	0.000147	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	8.37e-06	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	8.14e-06	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	8.11e-06	0.000142	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	8.07e-06	0.000141	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	8.03e-06	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	7.8e-06	0.000136	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—pancreatic cancer	7.75e-06	0.000135	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	7.75e-06	0.000135	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	7.53e-06	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	7.46e-06	0.00013	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	7.26e-06	0.000127	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	7.19e-06	0.000125	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	7.06e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	7.05e-06	0.000123	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—pancreatic cancer	7.04e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	7.01e-06	0.000122	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	6.84e-06	0.000119	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	6.7e-06	0.000117	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—pancreatic cancer	6.5e-06	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	6.33e-06	0.00011	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	6.27e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	6.26e-06	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	6.15e-06	0.000107	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	6.15e-06	0.000107	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	6.1e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—pancreatic cancer	5.83e-06	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	5.81e-06	0.000101	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	5.7e-06	9.94e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—pancreatic cancer	5.48e-06	9.55e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	5.38e-06	9.39e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—pancreatic cancer	5.32e-06	9.27e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—pancreatic cancer	5.03e-06	8.77e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	4.96e-06	8.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.95e-06	8.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—pancreatic cancer	4.79e-06	8.35e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	4.58e-06	7.98e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—pancreatic cancer	4.06e-06	7.07e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	4.04e-06	7.05e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	6.54e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—pancreatic cancer	3.06e-06	5.34e-05	CbGpPWpGaD
